Zocor 80 Mg Dose Remains Appropriate Option, FDA And Merck Agree
This article was originally published in The Pink Sheet Daily
JAMA editorial suggests that 80 mg Zocor dose should be used with caution, given rate of myopathy reported in "A to Z" trial. FDA and Merck both feel that current Zocor labeling appropriately describes dosing options.
You may also be interested in...
Merck’s anti-PD-1 therapy Keytruda keeps piling up new indications, including three approved by US FDA in just two weeks – all during a pandemic. The remarkable therapy has been a centerpiece for an equally remarkable period of regulatory innovation.
Commissioner Stephen Hahn was largely spared any direct criticism during a very long House hearing on COVID-19 response activities. That is a promising sign for the agency.
In the latest reminder of how badly industry lost the argument over the value of incremental improvements in formulations, US is proposing enhanced Medicaid rebates on virtually all new formulations of existing brands.